(Q45248983)

11 December 2017

Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists (English)

1 reference

11 December 2017

0 references

Elena H Chartoff

1

1 reference

11 December 2017

Carrie L Heusner

series ordinal

2

1 reference

11 December 2017

Richard D Palmiter

series ordinal

3

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

11 December 2017

Neuropsychopharmacology

1 reference

11 December 2017

30

1 reference

11 December 2017

7

1 reference

11 December 2017

1324-1333

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300678

11 December 2017

0 references

cites work

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Dopamine modulates release from corticostriatal terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The glutamatergic dysfunction hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Metabotropic glutamate receptors mGluR1alpha and mGluR2/3 display dynamic expression patterns in developing rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Phencyclidine supersensitivity in rats with neonatal dopamine loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Diverse psychotomimetics act through a common signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Feeding behavior in dopamine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

I. Parkinson's disease: Studies with an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Adipsia and Aphagia after 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300678

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300678

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference